Resonant Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $694K | Buy |
1,558
+108
| +7% | +$48.1K | 0.04% | 199 |
|
|
2025
Q1 | $703K | Buy |
1,450
+183
| +14% | +$88.7K | 0.05% | 174 |
|
|
2024
Q4 | $510K | Buy |
1,267
+41
| +3% | +$16.5K | 0.04% | 204 |
|
|
2024
Q3 | $570K | Buy |
1,226
+145
| +13% | +$67.4K | 0.04% | 202 |
|
|
2024
Q2 | $507K | Buy |
1,081
+276
| +34% | +$129K | 0.04% | 203 |
|
|
2024
Q1 | $336K | Buy |
+805
| New | +$336K | 0.03% | 250 |
|